Rapid Micro Biosystems (Rapid Micro Biosystems) ROCE % : -48.26% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Rapid Micro Biosystems ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Rapid Micro Biosystems's annualized ROCE % for the quarter that ended in Mar. 2024 was -48.26%.

Rapid Micro Biosystems ROCE % Historical Data

The historical data trend for Rapid Micro Biosystems's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Micro Biosystems ROCE % Chart

Rapid Micro Biosystems Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-86.81

-88.60

-34.05

-32.04

-38.21

Rapid Micro Biosystems Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial													-35.92	-39.34	-41.12	-37.64	-48.26

Rapid Micro Biosystems ROCE % Calculation

Rapid Micro Biosystems's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-56.563	/	( ( (190.65 - 19.05)	+	(143.452 - 18.986) )	/ 2 )
	=	-56.563	/	( (171.6	+	124.466)	/ 2 )
	=	-56.563	/	148.033
	=	-38.21 %

Rapid Micro Biosystems's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-57.092	/	( ( (143.452 - 18.986)	+	(127.731 - 15.6) )	/ 2 )
	=	-57.092	/	( ( 124.466	+	112.131 )	/ 2 )
	=	-57.092	/	118.2985
	=	-48.26 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Rapid Micro Biosystems (NAS:RPID) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Rapid Micro Biosystems ROCE % Related Terms

Thank you for viewing the detailed overview of Rapid Micro Biosystems's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Micro Biosystems (Rapid Micro Biosystems) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rapid Micro Biosystems Inc (NAS:RPID) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1001 Pawtucket Boulevard West, Suite 280, Lowell, MA, USA, 01854

Website

https://www.rapidmicrobio.com

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Executives

Sean M Wirtjes	officer: Chief Financial Officer	C/O VARIAN, INC., 3120 HANSEN WAY, M/S D-083, PALO ALTO CA 94304-1030
Spignesi Robert G. Jr.	director, officer: President and CEO	C/O RAPID MICRO BIOSYSTEMS, INC., 1001 PAWTUCKET BOULEVARD WEST, SUITE 280, LOWELL MA 01854
Kirk Malloy	director	5200 ILLUMINA WAY, SAN DIEGO CA 92122
Kennedy Lewis Capital Partners Master Fund Ii Lp	10 percent owner	111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120
Klm Gp Llc	10 percent owner	80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004
Kennedy Lewis Capital Partners Master Fund Iii Lp	10 percent owner	111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120
Kennedy Lewis Gp Ii Llc	10 percent owner	111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120
Kennedy Lewis Gp Iii Llc	10 percent owner	111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120
Kennedy Lewis Investment Holdings Ii Llc	10 percent owner	111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120
Kennedy Lewis Investment Management Llc	10 percent owner	80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004
Kennedy Lewis Management Lp	10 percent owner	225 LIBERTY STREET, SUITE 4210, NEW YORK NY 10281
David Chene	10 percent owner	80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004
Darren Richman	10 percent owner	80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004
Inese Lowenstein	director	C/O RAPID MICRO BIOSYSTEMS INC, 1001 PAWTUCKET BOULEVARD WEST, SUITE 280, LOWELL MA 01854
Richard A Keys	officer: CHIEF COMMERCIAL OFFICER	C/O RAPID MICRO BIOSYSTEMS INC, 1001 PAWTUCKET BOULEVARD, SUITE 280, LOWELL MA 01854